Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City
Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City
复制标题
DOI：
10.1016/j.drugalcdep.2015.06.006
复制
发表时间：
2015-08-01
影响因子：
4.2
通讯作者：
Amesty, Silvia
中科院分区：
文献类型：
--
作者：
Lewis, Crystal Fuller;Rivera, Alexis V.;Amesty, Silvia
背景：药房注射器的使用可能是向注射吸毒者（PWID）提供艾滋病毒预防资源的机会。我们研究了药房随机干预措施对降低纽约市注射吸毒者注射风险的影响。方法：药房 (n = 88) 被随机分为干预组、一级对照组和二级对照组。干预药房接受了深入的减少伤害培训，招募注射器客户在研究中注射药物，并提供额外服务（即艾滋病毒预防/医疗/社会服务转介、注射器处置容器和减少伤害印刷材料）。一级控制药房招募注射毒品的注射器顾客，不提供额外服务，二级控制药房不招募注射器顾客（不包括在本分析中），但参与药房工作人员调查，以评估干预对药房工作人员的影响。招募的注射器客户接受了基线和 3 个月的 ACASI 随访。考察了注射吸毒者注射风险/保护行为的干预效果。结果：共有482名注射吸毒者完成了基线和随访调查。注射吸毒者大多是西班牙裔/拉丁裔男性，平均年龄 43.6 岁。调整后，干预组中的注射吸毒者在 3 个月的随访中更有可能报告始终使用无菌注射器（PR = 1.24；95% CI：1.04-1.48）。 结论：这些研究结果证明，扩大注射吸毒者的药房服务可以鼓励使用无菌注射器，这可能会降低艾滋病毒高感染黑人和拉丁裔社区的注射风险。 (C) 2015 Elsevier Ireland Ltd. 保留所有权利。
Background: Pharmacy syringe access may be an opportunity to provide HIV prevention resources to persons who inject drugs (PWID). We examined the impact of a pharmacy-randomized intervention to reduce injection risk among PWID in New York City.Methods: Pharmacies (n = 88) were randomized into intervention, primary control, and secondary control arms. Intervention pharmacies received in-depth harm reduction training, recruited syringe customers who inject drugs into the study, and provided additional services (i.e., HIV prevention/medical/social service referrals, syringe disposal containers, and harm reduction print materials). Primary control pharmacies recruited syringe customers who inject drugs and did not offer additional services, and secondary control pharmacies did not recruit syringe customers (and are not included in this analysis) but participated in a pharmacy staff survey to evaluate intervention impact on pharmacy staff. Recruited syringe customers underwent a baseline and 3-month follow-up ACASI. The intervention effect on injection risk/protective behavior of PWID was examined.Results: A total of 482 PWID completed baseline and follow-up surveys. PWID were mostly Hispanic/Latino, male, and mean age of 43.6 years. After adjustment, PWID in the intervention arm were more likely to report always using a sterile syringe vs. not (PR= 1.24; 95% CI: 1.04-1.48) at 3-month follow-up.Conclusions: These findings present evidence that expanded pharmacy services for PWID can encourage sterile syringe use which may decrease injection risk in high HIV burdened Black and Latino communities. (C) 2015 Elsevier Ireland Ltd. All rights reserved.